{"id":44103,"date":"2022-05-19T11:01:23","date_gmt":"2022-05-19T09:01:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/the-global-atp-assays-market-is-projected-to-reach-usd-412-4-million-by-2027-researchandmarkets-com\/"},"modified":"2022-05-19T11:01:23","modified_gmt":"2022-05-19T09:01:23","slug":"the-global-atp-assays-market-is-projected-to-reach-usd-412-4-million-by-2027-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/the-global-atp-assays-market-is-projected-to-reach-usd-412-4-million-by-2027-researchandmarkets-com\/","title":{"rendered":"The Global ATP Assays Market is Projected to Reach USD 412.4 million by 2027 – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) – Global Forecast to 2027”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global ATP assays market is projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%.\n<\/p>\n

\nThe growth of this market can largely be attributed to the increasing food safety concerns, growing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology R&D, increasing prevalence of cancer and other chronic and infectious diseases, and the shift from culture-based tests to rapid tests.\n<\/p>\n

\nHowever, the high cost of instruments and inability to differentiate between extracellular and intracellular ATP is expected to restrain the growth of this market to a certain extent.\n<\/p>\n

\nThe consumables and accessories segment accounted for the largest share of the ATP assays, based on products in 2021<\/strong>\n<\/p>\n

\nBased on products, the ATP assays market is segmented into consumables & accessories, and instruments. The large share of the consumables & accessories segment is attributed to the extensive usage of ATP assays in research institutes to measure cell viability, increase in drug discovery due to a surge in chronic diseases which requires tumor testing and cell proliferation (in cancer), and the repeated purchase of consumables by pharmaceutical and biotechnology companies.\n<\/p>\n

\nContamination Testing accounted for the largest share of the market<\/strong>\n<\/p>\n

\nThe ATP assays market is segmented into contamination testing, disease testing, and drug discovery & development. The large share of the contamination testing segment can be attributed to the rising regulatory stringency of pharmaceutical and food & beverage companies for non-contaminated production, an increase in drug discovery post-COVID-19, and the need for cleaning and disinfection of environmental surfaces in hospitals.\n<\/p>\n

\nPharmaceutical & Biotechnology companies hold the largest share in the market, by end-user<\/strong>\n<\/p>\n

\nThe large share of Pharmaceutical & Biotechnology companies in the end-user segment can be attributed to the presence of a large number of pharmaceutical players with growing investments in this market, growing regulatory approvals for cell culture-based vaccines which require the use of ATP assays in contamination testing, commercial expansion of various pharmaceutical companies, the increasing demand for cell and gene therapies for chronic diseases, significant R&D in pharmaceutical & biopharmaceutical companies, increasing production of COVID-19 drugs, increasing adoption of cell-based assays for drug development, and the ease of use of ATP assays in contamination testing.\n<\/p>\n

\nThe APAC to witness the highest growth during the forecast period<\/strong>\n<\/p>\n

\nAsia Pacific is expected to grow at the highest CAGR during the forecast period of 2022-2027. This regional market is expected to register the highest growth rate during the forecast period as several APAC countries are witnessing a growing number of proteomics, genomics, and stem cell research activities.\n<\/p>\n

\nThe increasing incidence of chronic & infectious diseases, increasing drug discovery & development studies, favorable regulatory guidelines, the growing focus of global market players on emerging Asian economies, increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and research infrastructure modernization are some of the key factors driving the market for ATP assays.\n<\/p>\n

\nBreak of primary participants was as mentioned below:<\/strong>\n<\/p>\n